Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2023-10-24 00:00:00 ET · period of report 2023-10-23 · accession 0001415889-23-014485 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-24 | 2023-10-23 | CAPR | Bergmann Anthony | CFO | M - OptEx | $1.39 | +2,178 | 2,381 | +1,073% | +$3,027 |
| D | 2023-10-24 | 2013-10-23 | CAPR | Bergmann Anthony | CFO | M - OptEx | $0.00 | -2,178 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-23 | M | A | 2,178 | $1.39 | 2,381 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2013-10-23 | M | D | 2,178 | $0.00 | 0 | D | $1.39 · — to 2023-10-23 | 2,178 Common Stock | (F1) This option was granted on October 23, 2013 and was previously reported as covering 21,785 shares at an exercise price of $0.30 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F2) The shares vested annually over a 4 year period commencing on November 1, 2014. |